Replay available

argenx SE (ARGX) Q1 2026 Earnings Call

argenx SE (NASDAQ: ARGX) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Thu, May 7, 2026 at 8:30 AMendedReplay
argenx SE (ARGX) Q1 2026 Earnings Call

Hosted by

Featured presenters

Beth Del Draco

Vice President of Corporate Affairs

Karen Massey

Chief Executive Officer

Carl Bubis

Chief Financial Officer

Sandrine Perre-Girard

Chief Commercialization Officer

Hussain Ahmed

Analyst, Bank of America

Derek Ocellas

Analyst, Wells Fargo

James Gordon

Analyst, Barclays

Alex Thompson

Analyst, Stifel

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Argenx Se.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a0425b-4fce-7053-b74d-0d864b91b8a6 Created: 2026-08-27T08:34:39.616Z Duration: 3719.1836 Channels: 1 00:00:00.320 -- 00:00:02.080 Good morning. My name is Gavin, and I'll 00:00:02.080 -- 00:00:04.000 be your conference operator today. I would like 00:00:04.000 -- 00:00:05.600 to welcome everyone to the call. 00:00:12.559 -- 00:00:15.375 Thank you. I'd like to introduce Bethel 00:00:15.375 -- 00:00:17.535 Draco, Vice President of Corporate Affairs. You may 00:00:17.535 -- 00:00:18.574 now begin your call. 00:00:21.455 -- 00:00:24.335 Thank you. A press release was issued earlier 00:00:24.335 -- 00:00:26.814 today with our first quarter twenty twenty six 00:00:26.814 -- 00:00:28.974 financial results and business update. 00:00:29.590 -- 00:00:31.670 This can be found on our website along 00:00:31.670 -- 00:00:34.310 with the presentation for today's webcast. 00:00:34.710 -- 00:00:37.190 Before we begin on Slide two, I'd like 00:00:37.190 -- 00:00:39.510 to remind you that forward looking statements may 00:00:39.510 -- 00:00:42.485 be presented during this call. These may include 00:00:42.485 -- 00:00:44.645 statements about our future expectations, 00:00:44.805 -- 00:00:46.004 clinical development, 00:00:46.245 -- 00:00:49.285 regulatory timelines, the potential success of our product 00:00:49.285 -- 00:00:50.085 candidates, 00:00:50.325 -- 00:00:52.805 financial projections and upcoming milestones. 00:00:53.620 -- 00:00:57.140 Actual results may differ materially from those indicated 00:00:57.140 -- 00:00:58.420 by these statements. 00:00:58.820 -- 00:01:01.620 ARGX is not under any obligation to update 00:01:01.620 -- 00:01:04.180 statements regarding the future or to conform those 00:01:04.180 -- 00:01:07....